• Home
  • All News
  • About Us
  • Contact Us
  • Submit an article
We Are South Devon
Advertisement
  • Home
  • All News
  • About Us
  • Contact Us
  • Submit an article
No Result
View All Result
  • Home
  • All News
  • About Us
  • Contact Us
  • Submit an article
No Result
View All Result
We Are South Devon
No Result
View All Result
  • Home
  • All News
  • About Us
  • Contact Us
  • Submit an article

South West NHS researchers support trial proving first COVID-19 life-saving drug

WASD by WASD
June 18, 2020
in Community News
Coronavirus – important information about bus services in Torbay

Microscopic view of Coronavirus, a pathogen that attacks the respiratory tract. Analysis and test, experimentation. Sars. 3d render

NHS Trust researchers in the South West have supported national research which has proved a steroid can help save the lives of patients seriously ill with coronavirus.

The trials of the low-cost dexamethasone, which is said to be a major breakthrough in the treatment of the virus, were joined by the following NHS Trust members of the South West Peninsula Clinical Research Network:

RelatedPosts

The Real Abbot’s Way

Devon community centres urged to grab energy efficiency boost

Torbay’s young unsigned musicians – recognised and promoted In a new partnership

-Northern Devon Healthcare NHS trust
-Royal Cornwall Hospitals NHS Trust
-Royal Devon & Exeter NHS Foundation Trust
-Somerset NHS Foundation Trust
-Torbay & South Devon NHS Foundation Trust
-University Hospitals Plymouth NHS Trust
-Yeovil District Hospital NHS Foundation Trust

The drug reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19 and part of a worldwide trial testing existing treatments to see if they also work on COVID-19.

The Trusts’ teams joined the trial (named RECOVERY) of the drug, led by Oxford University, as one of 175 hospitals taking part which enrolled more than 11,500 patients in the UK.

The steroid cut the risk of death by a third for COVID patients on ventilators and by one fifth for those on oxygen treatment.

Doctor Tom Clark, Consultant Anaesthetist, study lead for Torbay and South Devon, said: “Contributing to large-scale, national research studies has always been vital to understand what treatments are best to help our patients and this has never been so true as during the COVID-19 pandemic.

“The findings from RECOVERY will help us better care for our patients hospitalised due to COVID-19 and I’m sure to give them more hope at this time.”

He praised research staff and patients: “Torbay Hospital has made a significant contribution to this study and I have been very impressed with the professionalism and work ethic of the whole research term, including the Research and Development staff, research nursing team and ward doctors without whom we could not have facilitated recruitment into this study.

“The biggest thank you goes to those patients who consented to involvement in RECOVERY; this is an on-going study that is testing other drugs and we hope that future results will also be positive.”

Doctor Fiona Roberts, Torbay and South Devon Research and Development Director, said: “This is really exciting news and great that Torbay has been part of this pivotal and ground-breaking trial. Research is a vital strand of the national strategy to deal with the coronavirus pandemic. These results show we are making progress and we are grateful to our patients and their families agreeing to be part of the trials and a testament to the dedication shown by the research and clinical teams involved in supporting this crucial work.”

The UK Government’s Chief Scientific Adviser, Sir Patrick Vallance, said: “This is tremendous news today from the Recovery trial showing that dexamethasone is the first drug to reduce mortality from COVID-19. It is particularly exciting as this is an inexpensive widely available medicine.

“This is a ground-breaking development in our fight against the disease, and the speed at which researchers have progressed finding an effective treatment is truly remarkable. It shows the importance of doing high-quality clinical trials and basing decisions on the results of those trials.”

Dr Ray Sheridan, Clinical Research Fellow at the University of Exeter and Consultant at the RD&E, set up the RECOVERY trial in Exeter. He said: “It’s fantastic to be involved in a trial that can save lives. This large-scale trial has had an incredibly swift turnaround, which is only possible because of the incredible staff, research nurses and infrastructure of the NHS. We’re all hugely grateful to the patients who have agreed to take part in RECOVERY – they’re helping us to improve treatment and save lives.”

In March the RECOVERY (Randomised Evaluation of COVid-19 thERapY) trial was established as a randomised clinical trial to test a range of potential treatments for COVID-19, including low-dose dexamethasone (a steroid treatment).

Peter Horby, Professor of Emerging Infectious Diseases in the Nuffield Department of Medicine, University of Oxford, and one of the Chief Investigators for the trial, said: “Dexamethasone is the first drug to be shown to improve survival in COVID-19. This is an extremely welcome result. The survival benefit is clear and large in those patients who are sick enough to require oxygen treatment, so dexamethasone should now become the standard of care in these patients. Dexamethasone is inexpensive, on the shelf, and can be used immediately to save lives worldwide.”

You can join us on our social media pages, follow us on Facebook or Twitter and keep up to date with whats going on in South Devon.

Got a news story, blog or press release that you’d like to share or want to advertise with us? Contact us

Related Posts

The Real Abbot’s Way
Community News

The Real Abbot’s Way

July 12, 2025
Devon community centres urged to grab energy efficiency boost
Community News

Devon community centres urged to grab energy efficiency boost

July 11, 2025
Torbay’s young unsigned musicians – recognised and promoted In a new partnership
Community News

Torbay’s young unsigned musicians – recognised and promoted In a new partnership

July 11, 2025
Award-winning children’s authors Philip Reeve and Sarah McIntyre announced as partners patrons of Libraries Unlimited
Community News

Award-winning children’s authors Philip Reeve and Sarah McIntyre announced as partners patrons of Libraries Unlimited

July 11, 2025
Rebecca Smith MP welcomes major defence investment as Helsing announces UK’s first resilience factory in Plymouth
Community News

Rebecca Smith MP presses Defence Secretary for promised £4bn funding pot, benefiting local defence businesses

July 11, 2025
Junior doctor strikes set to cause major disruption to NHS routine care
Community News

Train to be a nurse with the class of 2026

July 11, 2025
  • Home
  • All News
  • About Us
  • Contact Us
  • Submit an article

© 2023 We Are South Devon Brought to you by Griffiths Networking

No Result
View All Result
  • Home
  • All News
  • About Us
  • Contact Us
  • Submit an article

© 2023 We Are South Devon Brought to you by Griffiths Networking